Press

Graymark Capital, In Partnership with Jadian Capital, Completes $68,000,000 Life Sciences Acquisition In Carlsbad, CA

San Francisco, CA, March 2022 – Continuing the expansion of its "Gray Matter" Life Science Program, Graymark Capital, Inc., in partnership with Jadian Capital, has acquired a 205,000 square foot Life Science / R&D campus at 2051 Palomar Airport Road in Carlsbad, CA. 2051 Palomar Airport Road was originally designed for the research and development division of the Hughes Aircraft Corporation in the 1970s. Formerly known as Space + Craft, the property boasts significant architecture and amenities, including a state of...

Graymark Capital’s “Gray Matter” Life Science Initiative Recapitalizes 230,000 SF Life Science Building in San Carlos, California

San Francisco, CA, February 2022 – Graymark Capital, Inc. completed a recapitalization of its 230,000 square foot life science project in San Carlos, CA with BentallGreenOak, a global real estate investment advisor. 150 Industrial is an existing life science building that will be re-imagined with new exterior façade, outdoor amenity areas and modern lab buildout. The property has the largest available floor plate on the Peninsula for life sciences and significant infrastructure in power and systems. The project was formerly home...

Graymark Capital Expands Into Austin, Texas With Acquisition of 603,200 SF Commercial Portfolio in Southeast Austin

San Francisco, CA, July 2021 – Graymark Capital, Inc., in partnership with BentallGreenOak, a global real estate investment advisor, has acquired a two-building office / R&D / life science / data center portfolio totaling 603,200 square feet in the MetCenter submarket of Austin, Texas. The buildings, known as Met Center 10 and Met Center 15, are Graymark Capital’s first investments in the Austin market. Met Center 10 is a two-story, 345,600 sf project fully occupied by PPD, Inc. and the Texas Department...

Graymark Capital Completes $56,750,000 Acquisition in Palo Alto, CA

San Francisco, CA, May 2021 – Continuing expansion of its active Life Science Program, Graymark Capital, Inc., has completed at $56.75 million acquisition of 3 office R&D properties totaling 100,000 sf in Palo Alto, California. The properties, located at 2197 & 2225 E Bayshore Road and 1050 East Meadow Circle, were purchased under Graymark Capital’s Life Science Program, which focuses on well-located infill projects in major life science clusters. 2197 E Bayshore Road is a 23,000 sf single story R&D building that...

Graymark Capital, In Partnership with Monument Square Investment Group, Completes Life Science Acquisition In Palo Alto, CA

San Francisco, CA, December 2020 – Continuing expansion of its active Life Science Program, Graymark Capital, Inc., in partnership with Monument Square Investment Group (“MSIG”), has acquired a 24,000 square foot Life Science campus at 3960 and 3980 Fabian Way in Palo Alto, California. Fabian Way is a two-building Life Science project located in the Peninsula submarket of the San Francisco Bay Area. The property, formerly leased to Johnson & Johnson subsidiary Verb Surgical, is currently vacant. Graymark will modernize...

Graymark Capital, In Partnership with Nuveen Real Estate, Completes $99,000,000 Life Science Acquisition In San Carlos, CA

San Francisco, CA, December 2019 – Graymark Capital, Inc., in partnership with Nuveen Real Estate, has acquired a 230,000 square foot single tenant Life Science building for $99 million. 150 Industrial Road is an institutional-quality Life Science project located in the Peninsula submarket of the San Francisco Bay Area. The property is 100% leased to leading global pharmaceutical company, Mylan Pharmaceuticals, and serves as the development facility for the company's dry inhalant antibiotic used to treat cystic fibrosis patients.  The property was...